Yang, L., He, L., Zhang, Y., Fu, M., Li, X., & Luo, Z. (2026). SHR‐1703, a novel long‐acting anti‐interleukin‐5 monoclonal antibody, in asthma patients: A randomized, double‐blind, placebo‐controlled phase 1 study. Wiley. https://doi.org/10.1002/bcp.70439
Citazione stile Chigago Style (17a edizione)Yang, Ling, Lixiu He, Yajun Zhang, Meng Fu, Xiaotong Li, e Zhu Luo. SHR‐1703, a Novel Long‐acting Anti‐interleukin‐5 Monoclonal Antibody, in Asthma Patients: A Randomized, Double‐blind, Placebo‐controlled Phase 1 Study. Wiley, 2026. https://doi.org/10.1002/bcp.70439.
Citatione MLA (9a ed.)Yang, Ling, et al. SHR‐1703, a Novel Long‐acting Anti‐interleukin‐5 Monoclonal Antibody, in Asthma Patients: A Randomized, Double‐blind, Placebo‐controlled Phase 1 Study. Wiley, 2026. https://doi.org/10.1002/bcp.70439.